Jane Iles summarises a recent systematic review of digital interventions for perinatal mental health, which highlights a mixed bag of heterogeneous studies in this field.
[read the full story...]
Suzanne Dash considers the findings of a promising new small randomised controlled trial, which aims to reduce delusional conviction in people with schizophrenia who experience persecutory delusions.
[read the full story...]
This review of smoking cessation for patients with head and neck cancer included 8 studies ( 3 RCTs) and suggests that those receiving counseling had a 26% higher quit rate than with controls
[read the full story...]
GPs Tom Rowley and Michael Horsfield write their debut MSK Elf blog on a recent systematic review, which investigates the most cost-effective interventions for the management of whiplash-associated and neck pain-associated disorders.
[read the full story...]
Sarah Knowles reviews a recent meta-analysis about the effects of blinding on the outcomes of psychotherapy and pharmacotherapy for adult depression.
[read the full story...]
Alan Underwood appraises a recent RCT of the effectiveness and cost-effectiveness of a school-based CBT programme (FRIENDS) to help prevent anxiety and low mood in children.
[read the full story...]
Ioana Cristea reviews the NIHR-DC Highlight on cognitive therapies for depression, published online today, which summarises three NIHR-funded trials (REEACT, CoBalT and PREVENT) looking at cCBT, CBT and MBCT for depression in adults.
[read the full story...]
Shirley Reynolds laments the lack of recent high quality evidence, as she reviews a recent meta-analysis of psychological treatment of depression in college students.
[read the full story...]
Guy Goodwin reviews a new paper in the Lancet Psychiatry by Jauhar, McKenna and Laws, that calls into question the trustworthiness of the NICE bipolar disorder guidance.
[read the full story...]
Sarah McDonald considers the findings of the CoBalT RCT long-term follow-up, which finds that CBT plus antidepressants are clinically and cost effective for treatment-resistant depression in primary care.
[read the full story...]
